Increased uptake of
glucose, a general hallmark of malignant
tumors, leads to an accumulation of intermediate metabolites of glycolysis. We investigated whether the high supply of these intermediates promotes their flow into
UDP-sugars, and consequently into
hyaluronan, a
tumor-promoting matrix molecule. We quantified
UDP-
N-Acetylglucosamine (
UDP-GlcNAc) and
UDP-glucuronic acid (
UDP-GlcUA) in human
breast cancer biopsies, the levels of
enzymes contributing to their synthesis, and their association with the
hyaluronan accumulation in the
tumor. The content of
UDP-GlcUA was 4 times, and that of
UDP-GlcNAc 12 times higher in the
tumors as compared to normal glandular tissue obtained from breast reductions. The surge of
UDP-GlcNAc correlated with an elevated
mRNA expression of
glutamine-fructose-6-phosphate aminotransferase 2 (GFAT2), one of the key
enzymes in the biosynthesis of
UDP-GlcNAc, and the expression of GFAT1 was also elevated. The contents of both
UDP-sugars strongly correlated with
tumor hyaluronan levels. Interestingly,
hyaluronan content did not correlate with the
mRNA levels of the
hyaluronan synthases (HAS1-3), thus emphasizing the role of the
UDP-
sugar substrates of these
enzymes. The
UDP-sugars showed a trend to higher levels in ductal vs. lobular
cancer subtypes. The results reveal for the first time a dramatic increase of
UDP-sugars in
breast cancer, and suggest that their high supply drives the accumulation of
hyaluronan, a known promoter of
breast cancer and other
malignancies. In general, the study shows how the disturbed
glucose metabolism typical for malignant
tumors can influence cancer microenvironment through
UDP-sugars and
hyaluronan.